Niadyne

Niadyne is a biopharmaceutical company specializing in the development of niacin-based compounds for skin health and therapeutic applications. The company's core technology, Pro-Niacin, utilizes lipophilic derivatives of nicotinic acid to enhance delivery into the skin, where it promotes DNA repair and strengthens the skin barrier. Niadyne's commercial skincare brand, NIA24, was acquired by StriVectin in 2015 to expand its dermatological portfolio. Its pharmaceutical division, Niadyne Pharma, focuses on clinical programs for the treatment of actinic keratosis and the prevention of non-melanoma skin cancer. The company's research is rooted in the science of NAD+ metabolism and its role in maintaining genomic integrity and cellular energy.